Wikidata

(Q40073564)

English

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo

scientific article

In more languages

Statements

title
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017
author name string
Robert D Loberg
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017
Chi Ying
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017
Matt Craig
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017
Lashon L Day
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017
Chris Neeley
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017
Kirk Wojno
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017
Linda A Snyder
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017
publication date
1 October 2007
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017
page(s)
9417-9424
1 reference
stated in
Europe PubMed Central
PubMed ID
17909051
retrieved
17 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40073564&oldid=2120278145"